Nvigen Revenue and Competitors
Estimated Revenue & Valuation
- Nvigen's estimated annual revenue is currently $2M per year.
- Nvigen's estimated revenue per employee is $155,000
Employee Data
- Nvigen has 13 Employees.
- Nvigen grew their employee count by 0% last year.
Nvigen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director, Operation and Lab | Reveal Email/Phone |
2 | Product Development Manager | Reveal Email/Phone |
3 | President and CEO | Reveal Email/Phone |
4 | Data Technology | Reveal Email/Phone |
Nvigen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Nvigen?
Nvigen is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Our proprietary nanoparticle-imaging-delivery (NIDâ„¢) platform enables the engineering of nanoparticles with optimal size, shape, surface, magnetic and optical properties that can be used in sequencing, biopsy, genomics, diagnostics, gene/cell therapy, and drug delivery. We seek to integrate the versatility of nanoscience and innovation to develop solutions that can empower biomedical research.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nvigen News
2022-04-19 - Global Magnetic Nanoparticles Market 2022 Key Drivers and ...
Cathay Industries; TodaKogyo; NN-Labs; Nanoshel; NanoComposix; Nvigen; CAN-GmbH; Nanografi; Cytodiagnostics.
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 13 | -24% | $2.1M |
#2 | $2.1M | 13 | N/A | N/A |
#3 | $0.4M | 13 | -24% | $34M |
#4 | $0.4M | 13 | -70% | $13M |
#5 | $0.4M | 13 | 44% | $16.3M |